...
首页> 外文期刊>Drug delivery and translational research >Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study
【24h】

Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study

机译:Nisoldipine通过溶剂蒸发技术的无定形固体分散方法:制备,表征,体外,体内评估,并扩大可行性研究

获取原文
获取原文并翻译 | 示例
           

摘要

The present study was designed to determine the applicability of a newly derived dimensionless number precipitation parameter, "supersaturation holding capacity (SHC)" in development of amorphous solid dispersion (ASD) of a rapidly crystallizing drug, nisoldipine. Also, ASD preparation from lab scale formulation technique to scalable spray drying technique followed by oral bioavailability study was demonstrated. Solution state screening of polymers was performed by determining nucleation induction time (tin) and SHC. With screened polymers, lab scale ASDs of nisoldipine were prepared using rotary evaporation (solvent evaporation) method, and the optimized stable ASDs were scaled up by spray drying. The ASDs were characterized by DSC, PXRD, and FTIR for amorphous nature and evaluated for apparent solubility, dissolution, and solid-state stability improvement. The spray dried ASDs were additionally evaluated for micrometric properties and oral bioavailability study.PVP grades demonstrated superior crystal growth inhibition properties (with 2-4-fold enhancements in SHC). ASDs prepared by both lab scale and scale-up technique using PVP stabilized the amorphous nisoldipine via antiplasticization effect that maintained the stability under accelerated stability conditions (40 degrees C/75% RH) for 6 months. Additionally, FTIR study confirmed the role of intermolecular interactions in amorphous state stabilization of PVP-based solid dispersions. PVP-based spray dried ASDs improved the apparent solubility 4-fold for PVP K17 and more than 3-fold for remaining spray dried ASDs. The enhanced solubility was translated to improved dissolution of the drug when compared with crystalline and amorphous form complementing the outcome of the solution state study. The spray dried ASD showed 2.3 and > 3-fold the improvement in Cmax and AUC (0-24 h) respectively when compared with crystalline nisoldipine during oral bioavailability study which highlights the significance of SHC parameter of polymers. The spray dried ASD has shown improved micromeritics properties then crystalline nisoldipine in terms of flow behavior.This unique study provides a rational strategy for selection of appropriate polymer in development of ASDs that can tackle both precipitation during dissolution and amorphous state stabilization in solid state and also considers the SHC in scale-up study.
机译:本研究旨在确定新衍生的无量纲数沉淀参数,“超饱和保持能力(SHC)”在快速结晶的药物,Nisoldipine的无定形固体分散体(ASD)中的适用性。此外,从实验室规模配方技术到可伸缩喷雾干燥技术的ASD制备,然后进行了口服生物利用度研究。通过确定核切种诱导时间(锡)和SHC来进行聚合物的溶液状态筛选。利用筛选聚合物,使用旋转蒸发(溶剂蒸发)方法制备Nisoldipine的实验室尺度ASDS,通过喷雾干燥来缩放优化的稳定ASD。 ASDS的特征在于DSC,PXRD和FTIR用于无定形性,并评估表观溶解度,溶解和固态稳定性改善。另外评估喷雾干燥的ASDS用于微米性能,口服生物利用度研究。PVP等级显示出优异的晶体生长抑制性能(SHC中具有2-4倍的增强)。通过抗血栓形成效应稳定了使用PVP的实验室规模和扩展技术的ASDS,通过抗塑化效果稳定,使得在加速稳定条件下的稳定性(40℃/ 75%RH)保持6个月。另外,FTIR研究证实了分子间相互作用在PVP基固体分散体的非晶态稳定中的作用。基于PVP的喷雾干燥ASDS改善PVP K17的表观溶解度4倍,3倍以3倍用于剩余喷雾干燥ASDS。与结晶和无定形形式进行补充溶液状态研究的结果时,将增强的溶解度转化为改善药物的溶解。当在口服生物利用度研究期间,喷雾干燥ASD显示出2.3和> 3倍CMAX和AUC(0-24小时)的改善,突出了聚合物SHC参数的显着性。喷雾干燥的ASD显示出改善的微晶性质,然后在流动性方面进行了结晶Nisoldipine。该独特的研究提供了选择适当的聚合物在ASDS的开发中选择适当的聚合物,其在溶解期间沉淀和固体状态稳定化的适当聚合物。在扩大的研究中考虑SHC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号